Skip to content

Study · Animal study (in vivo) · rabbit · 1998

3 results

Thymosin alpha-1: evidence for an antiatherogenic effect.

Ademoglu E, Gökkuşu C, Oz B

Annals of nutrition & metabolism1 Jan 1998Cited by 7 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In hypercholesterolemic rabbits, thymosin alpha1 significantly decreased plasma TBARS levels.

    In plain wordsIn rabbits with high cholesterol, thymosin alpha‑1 lowered a blood marker of fat oxidation.

    Outcome
    DecreasePlasma TBARS (lipid peroxide) levels
    Study

    rabbitn: not reported in source

    rabbits with diet-induced hypercholesterolemia
    Comparator
    Hypercholesterolemic rabbits on normal diet without peptide
    Outcome group
    Lipids · Cardiovascular
    Studied dose
    25 microg/kg every other day · intraperitoneal · 14 daysAs given in this study (rabbit).

    Source sentences

    Summary
    Plasma and erythrocyte TBARS levels significantly decreased in the thymosin-alpha1-injected rabbits.
    3 context sentences
    Summary · context
    Hypercholesterolemic rabbits had high plasma and erythrocyte lipid peroxide (TBARS) levels compared to control animals fed a normal diet.
    Summary · context
    In groups II-IV, rabbits were fed a high-cholesterol diet 2% (w/w) for 10 weeks.
    Summary · context
    Thereafter, rabbits in group III were fed a normal diet for another 14 days and those in group IV were given a normal diet plus 25 microg/kg thymosin alpha1 intraperitoneally every other day for the same period.
  2. 02AnimalAnimal study (in vivo)Efficacy outcome

    In hypercholesterolemic rabbits, thymosin alpha1 significantly decreased erythrocyte TBARS levels.

    In plain wordsIn rabbits with high cholesterol, thymosin alpha‑1 lowered a marker of fat oxidation in red blood cells.

    Outcome
    DecreaseErythrocyte TBARS (lipid peroxide) levels
    Study

    rabbitn: not reported in source

    rabbits with diet-induced hypercholesterolemia
    Comparator
    Hypercholesterolemic rabbits on normal diet without peptide
    Outcome group
    Lipids · Cardiovascular
    Studied dose
    25 microg/kg every other day · intraperitoneal · 14 daysAs given in this study (rabbit).

    Source sentences

    Summary
    Plasma and erythrocyte TBARS levels significantly decreased in the thymosin-alpha1-injected rabbits.
    2 context sentences
    Summary · context
    In groups II-IV, rabbits were fed a high-cholesterol diet 2% (w/w) for 10 weeks.
    Summary · context
    Thereafter, rabbits in group III were fed a normal diet for another 14 days and those in group IV were given a normal diet plus 25 microg/kg thymosin alpha1 intraperitoneally every other day for the same period.
  3. 03AnimalAnimal study (in vivo)Efficacy outcome

    In hypercholesterolemic rabbits treated with thymosin alpha1, most of the lipid plaques were replaced by fibrous tissue.

    In plain wordsIn rabbits with high cholesterol, thymosin alpha‑1 treatment was followed by most lipid plaques turning into fibrous tissue.

    Outcome
    DecreaseLipid plaques replaced by fibrous tissue
    Study

    rabbitn: not reported in source

    rabbits with diet-induced hypercholesterolemia
    Outcome group
    Lipids · Cardiovascular
    Studied dose
    25 microg/kg every other day · intraperitoneal · 14 daysAs given in this study (rabbit).

    Source sentences

    Summary
    In thymosin-alpha1-treated animals (group IV), most of the lipid plaques were replaced by fibrous tissue.
    2 context sentences
    Summary · context
    In groups II-IV, rabbits were fed a high-cholesterol diet 2% (w/w) for 10 weeks.
    Summary · context
    Thereafter, rabbits in group III were fed a normal diet for another 14 days and those in group IV were given a normal diet plus 25 microg/kg thymosin alpha1 intraperitoneally every other day for the same period.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.